Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Girish Modi and Dinesh Naidoo.
Connection Strength

1,002
  1. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
    View in: PubMed
    Score: 0,338
  2. Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
    View in: PubMed
    Score: 0,094
  3. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,089
  4. Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. J Pharm Pharm Sci. 2018; 21(1):94-109.
    View in: PubMed
    Score: 0,038
  5. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
    View in: PubMed
    Score: 0,034
  6. Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System. AAPS PharmSciTech. 2017 Apr; 18(3):671-685.
    View in: PubMed
    Score: 0,034
  7. Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
    View in: PubMed
    Score: 0,033
  8. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
    View in: PubMed
    Score: 0,031
  9. Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
    View in: PubMed
    Score: 0,031
  10. Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
    View in: PubMed
    Score: 0,029
  11. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
    View in: PubMed
    Score: 0,028
  12. Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int J Pharm. 2013 May 01; 448(1):267-81.
    View in: PubMed
    Score: 0,028
  13. Novel high-viscosity polyacrylamidated chitosan for neural tissue engineering: fabrication of anisotropic neurodurable scaffold via molecular disposition of persulfate-mediated polymer slicing and complexation. Int J Mol Sci. 2012 Oct 29; 13(11):13966-84.
    View in: PubMed
    Score: 0,027
  14. Composite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate. J Drug Deliv. 2012; 2012:579629.
    View in: PubMed
    Score: 0,026
  15. Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with ß-amyloid aggregates of Alzheimer's disease. Pharm Res. 2012 Nov; 29(11):3075-89.
    View in: PubMed
    Score: 0,026
  16. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
    View in: PubMed
    Score: 0,025
  17. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv. 2011; 2011:939851.
    View in: PubMed
    Score: 0,024
  18. In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011 Jan 19; 12(1):694-724.
    View in: PubMed
    Score: 0,024
  19. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
    View in: PubMed
    Score: 0,021
  20. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int J Mol Sci. 2009 Jun 03; 10(6):2510-57.
    View in: PubMed
    Score: 0,021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.